drugset / Trial / NCT01185743

Antipsychotics and Gene Expression in Soft Tissues

NCT01185743

Phase 4 Completed 16 enrolled Medical University of Vienna
RandomizedParallel-groupDouble-blindBasic science

Summary

Schizophrenia is a severe chronic and disabling mental disorder and is associated with a significant reduction in life expectancy. Atypical antipsychotic treatment compliance may be jeopardized because of drug induced weight gain and abnormalities in carbohydrate and lipid metabolism. Aim: to gain data on drug related effects on gene expression and regulation with special regard to glucose metabolism.

Timeline

Start
2010-07
Primary completion
2017-01-01
Completion
2017-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Olanzapine Small molecule 10 mg
Comparator Ziprasidone Small molecule 40 mg